Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: non-antibiotic antibacterials - GEn1E Lifesciences/University of Maryland, Baltimore

Next Previous
Drug Profile

Research programme: non-antibiotic antibacterials - GEn1E Lifesciences/University of Maryland, Baltimore

Alternative Names: MUC1 decoy peptides; MUC1-Ecto-Domain anti-bacterial; MUC1-Ecto-Domain anti-bacterial agent; MUC1-ED; MUC1-ED non-antibiotic peptide; MUC1-ED program; Mucin-1 decoy peptides

Latest Information Update: 28 Nov 2020

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Maryland, Baltimore
  • Developer GEn1E Lifesciences; University of Maryland, Baltimore
  • Class Antibacterials; Peptides; Recombinant proteins
  • Mechanism of Action Epithelial cell adhesion molecule inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Pseudomonal infections

Most Recent Events

  • 28 Nov 2020 No recent reports of development identified for preclinical development in Pseudomonal-infections in USA
  • 29 Nov 2018 Preclinical trials is ongoing for Pseudomonal infections in USA
  • 19 Nov 2018 GEn1E Lifesciences enters into an exclusive option agreement with University of Maryland, Baltimore to license patent rights to MUC1 decoy peptides for Bacterial infections (Treatment, Prevention)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top